PD-1 and PD-L1 antibodies in cancer: current status and future directions

Overview of attention for article published in Cancer Immunology, Immunotherapy, February 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 50,737 followers.

RT @AndreasC466: #PD-1 and #PD-L1 antibodies in cancer: current status and future directions https://t.co/gwa3pTcDAS

RT @AndreasC466: #PD-1 and #PD-L1 antibodies in cancer: current status and future directions https://t.co/gwa3pTcDAS

RT @AndreasC466: #PD-1 and #PD-L1 antibodies in cancer: current status and future directions https://t.co/gwa3pTcDAS

RT @AndreasC466: #PD-1 and #PD-L1 antibodies in cancer: current status and future directions https://t.co/gwa3pTcDAS

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.